Skripsi
EFEK PEMBERIAN THYMOQUINONE TERHADAP EKSPRESI TUMOR NECROSIS FACTOR ALPHA (TNF-α) DAN INTERLEUKIN-1 BETA (IL-1β) PADA TIKUS PUTIH (Rattus Norvegicus) MODEL FIBROSIS GINJAL
Introduction: Chronic kidney disease is a progressive condition characterized by sustained inflammation and the development of renal fibrosis. A key mechanism contributing to tissue injury is the elevation of pro-inflammatory cytokines, particularly TNF-α and IL-1β, which are known to increase in the unilateral ureteral obstruction (UUO) model of renal fibrosis. Thymoquinone, the principal active component of Nigella sativa, exhibits antioxidant and anti-inflammatory properties that may suppress the activity of these cytokines. This study aimed to evaluate the effect of thymoquinone administration on TNF-α and IL-1β levels in a rat model of renal fibrosis. The results are expected to provide scientific support for the development of natural-based therapies to modulate inflammation and slow the progression of renal fibrosis. Methods: This laboratory-based experimental study employed a post-test only control group design. A total of 30 male Wistar rats were divided into six groups: sham-operated, negative control with olive oil, negative control without olive oil, and thymoquinone intervention groups at doses of 5 mg/kgBW, 10 mg/kgBW, and 20 mg/kgBW. TNF-α and IL-1β levels were measured using RNA PCR methods. Data were analyzed using the Statistical Package for the Social Sciences (SPSS). Results: Thymoquinone administration reduced the mean TNF-α levels in all UUO groups compared to the negative control, although the differences were not statistically significant. The greatest reduction was observed at the 10 mg/kgBW dose. In contrast, thymoquinone significantly decreased IL-1β levels, with the most optimal effect seen at the 20 mg/kgBW dose. Conclusion: Thymoquinone demonstrated a decreasing effect on TNF-α levels in the UUO model, although this reduction was not statistically significant, with the strongest response at the 10 mg/kgBW dose. Thymoquinone significantly reduced IL-1β levels, particularly at the 20 mg/kgBW dose. These findings support the potential of thymoquinone as an anti-inflammatory agent in attenuating the progression of renal fibrosis. Keywords: Thymoquinone, renal fibrosis, unilateral ureteral obstruction, TNF-α, IL-1β
| Title | Edition | Language |
|---|---|---|
| HISTOPATOLOGI GINJAL IKAN NILA (OREOCHROMIS NILOTICUS BLEEKER) YANG TERPAPAR AIR LIMBAH PABRIK KELAPA SAWIT | id |